Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01398280 · ClinicalTrials.gov registry record · Early Phase 1
Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation
A Early Phase 1 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
NCT01398280 is a Early Phase 1 study that has completed, run by University of California, San Diego. The registered enrollment target is 15 participants.
The verdict
NCT01398280, a Early Phase 1 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of topical aminocaproic acid on the immune system by assessing the levels of antimicrobial peptides in the skin of patients with rosacea. It is hypothesized that aminocaproic acid applied topically will alter the body's immune system in patients with rosacea by inhibiting activation of antimicrobial peptides.
Interventions
- DRUG Vehicle cream
- DRUG Topical aminocaproic acid (ACA) mixed with Vanicream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01398280
The ClinicalTrials.gov registry entry for NCT01398280 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle cream is the first listed.
NCT01398280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01398280 about?
NCT01398280 is a clinical study titled "Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation". The purpose of this study is to determine the effect of topical aminocaproic acid on the immune system by assessing the levels of antimicrobial peptides in the skin of patients with rosacea. It is hypothesized that aminocaproic acid applied topically will alter the body's immune system in patients w...
What is the current status of trial NCT01398280?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2011-07. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01398280?
The interventions under investigation include: Vehicle cream (DRUG), Topical aminocaproic acid (ACA) mixed with Vanicream (DRUG).
Who is sponsoring clinical trial NCT01398280?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.